PS9 - 2. Plasma trimethylamine N-oxide (TMAO) levels are associated with 18FDG-PET/CT determined vascular inflammation

Ruud S. Kootte,Fleur M. van der Valk,Geesje M. Dallinga-Thie,Zeneng Wang,Stanley L. Hazen,Erik S.G. Stroes,Max Nieuwdorp
DOI: https://doi.org/10.1007/s12467-013-0100-0
2013-11-01
Nederlands Tijdschrift voor Diabetologie
Abstract:Recent animal studies have shown a mechanistic link between the pro-atherosclerotic metabolite trimethylamine-Noxide (TMAO), derived from gut microbiota driven catabolism of dietary choline and carnitine, and atherosclerotic plaque formation, a finding which was substantiated in humans with cardiovascular disease (Hazen, Nature Medicine, 2013).
What problem does this paper attempt to address?